Browse by author
Lookup NU author(s): Matt Collison,
Professor Robert Hirt,
Professor Anil Wipat,
Dr Sirintra Nakjang
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
It is well known that microbes have an intricate role in human health and disease. However, targeted strategies for modulating human health through the modification of either human-associated microbial communities or associated human-host targets have yet to be realized. New knowledge about the role of microbial communities in the microbiota of the gastrointestinal tract (GIT) and their collective genomes, the GIT microbiome, in chronic diseases opens new opportunities for therapeutic interventions. GIT microbiota participation in drug metabolism is a further pharmaceutical consideration. In this review, we discuss how computational methods could lead to a systems-level understanding of the global physiology of the host-microbiota superorganism in health and disease. Such knowledge will provide a platform for the identification and development of new therapeutic strategies for chronic diseases possibly involving microbial as well as human-host targets that improve upon existing probiotics, prebiotics or antibiotics. In addition, integrative bioinformatics analysis will further our understanding of the microbial biotransformation of exogenous compounds or xenobiotics, which could lead to safer and more efficacious drugs.
Author(s): Collison M, Hirt RP, Wipat A, Nakjang S, Sanseau P, Brown JR
Publication type: Article
Publication status: Published
Journal: Briefings in Bioinformatics
Print publication date: 24/03/2012
ISSN (print): 1467-5463
ISSN (electronic): 1477-4054
Publisher: Oxford University Press
Altmetrics provided by Altmetric